News

Mother developing gene therapy for her son’s rare disease and 400 kids around the world

Published on: 14/03/2022

Mother developing gene therapy for her son’s rare disease and 400 kids around the world
Ecosystems

Špela Mirošević realised that her now 2 year old son Urban’s unusual development is not a regular cerebral palsy but a special case that is caused by a single malfunctioning gene called CTNNB1. This discovery was the turning point for Špela and her husband, as they didn’t lose hope, but started something that still amounts to a giant effort. They created the CTNNB1 Foundation in April 2021, and have raised about €1m in less than a year, against the goal of €2m.

The money collected in 2021 has already been directed towards preclinical studies focusing on treating the CTNNB1. This study is conducted with the help of a team of top scientists from around the globe, all of whom have come on board via Špela’s effort.The treatment in development is believed to be ready for use for Urban and 400 other children around the world with the same deficiency in early 2023. However, Špela says that it’s very likely many CTNNB1 deficiencies are undiscovered as pediatricians treat them as if they were palsies. CTNNB1 is properly diagnosed by dedicated genetic testing. Špela presented her case at the 2021 HealthDay.si conference. Her presentation in English can be watched here:

We invite you to spread this information. 

With your help, you will help raise the missing €1m. You will also raise awareness among pediatricians that perhaps misdiagnose kids with CTNNB1. And with enough resources and some clinical luck, Urban and his peers might grow up as healthy boys. 

NEWS​

Related News

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Applications Now Open: Spread & Scale Academy

1 Jul 2025
Do you have an innovation or solution that’s working well in one place and could make a difference elsewhere?

Securing funding for your innovation: The bid lifecycle

1 Jul 2025
This blog is the second instalment in our Bid Lifecycle series, where we explore the key stages involved in securing funding for innovative healthcare...

HLTH Brought the Energy to Amsterdam. Now It’s Vegas’ Turn.

26 Jun 2025
Next up: HLTH USA, October 19–22 in Las Vegas.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *